Company Advances Cardiac Amyloidosis Therapy through Attruby

BridgeBio is significantly boosted this progress of the innovative solution for ATTR-CM, employing the compound. Preliminary patient results reveals potential outcomes for individuals suffering with this severe condition. The focus highlights BridgeBio's dedication to addressing significant healthcare demands in this heart space. Attruby: BridgeBi

read more